Detalles de la búsqueda
1.
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
Br J Clin Pharmacol
; 81(6): 1142-52, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26799162
2.
The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.
Support Care Cancer
; 21(1): 201-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22669608
3.
Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients.
Qual Life Res
; 22(7): 1745-51, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23054499
4.
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.
Clin Pharmacol Ther
; 113(3): 712-723, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629403
5.
Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients.
Breast Cancer Res Treat
; 131(2): 619-25, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21922244
6.
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
Breast Cancer Res
; 13(2): R35, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21457545
7.
Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer.
Pharmacogenet Genomics
; 21(11): 760-8, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849928
8.
A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.
Cancer Invest
; 29(9): 617-25, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22011284
9.
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
Lancet Oncol
; 10(11): 1077-85, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880061
10.
PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Clin Cancer Res
; 14(21): 7116-26, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18981011
11.
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients.
Cancer Sci
; 99(10): 2045-54, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19016765
12.
Primary medical therapy and breast conservation treatment: the medical oncology perspective.
Gland Surg
; 7(6): 560-575, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30687629
13.
Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.
Oncotarget
; 9(16): 12796-12804, 2018 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29560110
14.
Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study.
Breast Cancer Res
; 9(2): R21, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17341292
15.
ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.
Breast J
; 18(6): 604-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23078524
16.
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
JAMA Oncol
; 3(11): 1538-1545, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28715540
17.
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.
Clin Pharmacokinet
; 55(10): 1239-1250, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27098059
18.
Adrenal insufficiency in intestinal obstruction from carcinomatosis peritonei--a factor of potential importance in symptom palliation.
J Pain Symptom Manage
; 29(4): 411-8, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15857745
19.
Inflammatory metastatic carcinoma of the colon: a case report and review of the literature.
Tumori
; 90(2): 253-5, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15237593
20.
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.
Cancer Med
; 2(2): 234-42, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23634291